Sarasota Memorial earns national accreditation for rectal cancer treatment

Hospital had to demonstrate ‘compliance with rigorous set of standards’

This is the Brian D. Jellison Cancer Institute at Sarasota Memorial Hospital in Sarasota. Image courtesy Sarasota Memorial

The Sarasota Memorial Hospital (SMH) Brian D. Jellison Cancer Institute has earned accreditation from the National Accreditation Program for Rectal Cancer (NAPRC), the hospital has announced.

This recognition is granted only “to those programs that are committed to providing the highest quality care to patients with rectal cancer,” a news release explains.

“Sarasota Memorial demonstrated compliance with a rigorous set of standards held by the NAPRC that address program management, clinical services, and quality improvement for rectal cancer patients,” the release points out. This designation is a result of the work being done at the Brian D. Jellison Cancer Institute to provide patients on the Suncoast with treatments and support found only at the nation’s best cancer centers, the release adds.

“At SMH, we are so proud that we have been granted this distinguished accreditation, achieved by only a handful of centers in the state,” said Dr. Richard Brown, chief program medical director of the Brian D. Jellison Cancer Institute at SMH, in the release. “This accreditation is just another example of the commitment of our physicians, staff and leadership to provide outstanding care to the Sarasota community.”

“The Sarasota Memorial Brian D. Jellison Cancer Institute established a multidisciplinary rectal cancer team, including medical and radiation oncology, surgery, pathology, radiology and gastroenterology,” the release points out, to achieve this accreditation. The members of the care team work together, “reviewing pertinent patient history and radiology and pathology reports, to determine the most appropriate course of treatment for all patients with rectal cancer prior to the initiation of any treatment, and every patient’s progress is continuously monitored by the team,” the release notes.

“I am extremely proud of the work of our entire team,” said Dr. Kenneth Meredith, chief of surgical oncology at SMH, in the release. “This accreditation is a testament to their dedication to providing specialized cancer care close to home.”

The NAPRC conducts a site visit every three years for accredited rectal cancer programs, which also are accredited by the American College of Surgeons Commission on Cancer, the release adds.